Compare ECOR & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | HYPR |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.6M | 83.2M |
| IPO Year | 2018 | 2021 |
| Metric | ECOR | HYPR |
|---|---|---|
| Price | $11.33 | $0.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $18.00 | $1.59 |
| AVG Volume (30 Days) | 80.6K | ★ 372.3K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,032,000.00 | $13,563,000.00 |
| Revenue This Year | $33.60 | $50.75 |
| Revenue Next Year | $30.40 | $29.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.20 | 5.22 |
| 52 Week Low | $4.41 | $0.75 |
| 52 Week High | $12.70 | $2.22 |
| Indicator | ECOR | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 43.68 |
| Support Level | $5.70 | N/A |
| Resistance Level | N/A | $1.19 |
| Average True Range (ATR) | 0.69 | 0.04 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 64.23 | 64.55 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.